Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Swain

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
Transfusion|February 3, 2017
Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitalsMichael F Leahy, Axel Hofmann, Simon Towler, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2006
Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfaVincent G Bain, Eric M Yoshida, Kelly D Kaita, et al.
BMC Gastroenterology|September 13, 2015
Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative dataJack X Q Pang, Erin Ross, Meredith A Borman, et al.
Alimentary Pharmacology & Therapeutics|July 15, 2017
Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriersA A Shaheen, M AlMattooq, S Yazdanfar, et al.
Biofouling|November 26, 2011
Evaluation of the performance enhancement of silicone biofouling-release coatings by oil incorporationK Truby, C Wood, J Stein, et al.
The American Journal of Gastroenterology|November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis BA M Di Bisceglie, T L Fong, M W Fried, et al.
Canadian Journal of Gastroenterology & Hepatology|March 13, 2014
The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinationsJack X Q Pang, Faruq Pradhan, Scott Zimmer, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis CA M Di Bisceglie, M Shindo, T L Fong, et al.
Annals of Hepatology|May 18, 2019
Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV CarriersConar R O'Neil, Stephen E Congly, M Sarah Rose, et al.
Alimentary Pharmacology & Therapeutics|September 14, 2017
Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' replyA A Shaheen, M Al-Mattooq, S Yazdanfar, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
Transfusion|February 3, 2017
Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitalsMichael F Leahy, Axel Hofmann, Simon Towler, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2006
Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfaVincent G Bain, Eric M Yoshida, Kelly D Kaita, et al.
BMC Gastroenterology|September 13, 2015
Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative dataJack X Q Pang, Erin Ross, Meredith A Borman, et al.
Alimentary Pharmacology & Therapeutics|July 15, 2017
Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriersA A Shaheen, M AlMattooq, S Yazdanfar, et al.
Biofouling|November 26, 2011
Evaluation of the performance enhancement of silicone biofouling-release coatings by oil incorporationK Truby, C Wood, J Stein, et al.
The American Journal of Gastroenterology|November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis BA M Di Bisceglie, T L Fong, M W Fried, et al.
Canadian Journal of Gastroenterology & Hepatology|March 13, 2014
The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinationsJack X Q Pang, Faruq Pradhan, Scott Zimmer, et al.
Hepatology (Baltimore, Md.)|September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis CA M Di Bisceglie, M Shindo, T L Fong, et al.
Annals of Hepatology|May 18, 2019
Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV CarriersConar R O'Neil, Stephen E Congly, M Sarah Rose, et al.
Alimentary Pharmacology & Therapeutics|September 14, 2017
Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' replyA A Shaheen, M Al-Mattooq, S Yazdanfar, et al.
Pageof 23